INCONTESTABLE® Blog
Trademark Application for Fruity Pebbles’ Colors—“Yabba-Dabba-Delicious” but Not Protectable
March 8, 2024
Webinar
Advertising Self-Regulation in 2024: Q&A with NAD Vice President Laura Brett
January 30, 2024
Podcasts
A Conversation with Vaishali Udupa, Commissioner for Patents of the USPTO
February 27, 2024
Never miss an Insight.
Sign upEvent
Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
February 15, 2024
Webinar
Event
Doctrine of Equivalents After VLSI Technology Decision: Navigating DOE Amid Tight Policing; Avoiding Pitfalls Doctrine of Equivalents After VLSI Technology Decision: Navigating DOE Amid Tight Policing; Avoiding Pitfalls
January 18, 2024
Webinar
Event
Inducement to Infringe in Hatch-Waxman Litigation: Strategies for Patent Drafting, Prosecution, and Litigation Inducement to Infringe in Hatch-Waxman Litigation: Strategies for Patent Drafting, Prosecution, and Litigation
December 14, 2023
Webinar
Event
Patent Infringement, Safe Harbor, and Drug Development: Navigating the Uncertain Boundaries, Recent Court Treatment Patent Infringement, Safe Harbor, and Drug Development: Navigating the Uncertain Boundaries, Recent Court Treatment
November 30 2023
Webinar
At the PTAB Blog
Substitute Claims Upheld as Prior Art Is Inapplicable to Pharmaceutical Compositions Substitute Claims Upheld as Prior Art Is Inapplicable to Pharmaceutical Compositions
October 27, 2023
Event
Prosecution and Specification Statements: Implications for Patent Claim Construction in Parent and Sibling Applications and PTAB and District Court/Federal Circuit Litigation Prosecution and Specification Statements: Implications for Patent Claim Construction in Parent and Sibling Applications and PTAB and District Court/Federal Circuit Litigation
August 24, 2023
Webinar
Event
Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World
July 6, 2023
Webinar
Articles
REMS Patents: Listability and Other Issues REMS Patents: Listability and Other Issues
July 4, 2023
International In-House Counsel JournalEvent
Obtaining and Managing REMS Patents: What Patent Prosecutors Need to Know, USPTO and FDA Policies and Rules Obtaining and Managing REMS Patents: What Patent Prosecutors Need to Know, USPTO and FDA Policies and Rules
March 21, 2023
Webinar
Event
2023 Orange Book Listing Recent Developments 2023 Orange Book Listing Recent Developments
February 14, 2023
Webinar
Event
Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment Biologics Price Competition and Innovation Act: Purple Book, Dispute Resolution, Exclusivities, and Court Treatment
January 5, 2023
Webinar
Federal Circuit IP Blog
Will 2023 Be the Year of § 112 at the Supreme Court? Will 2023 Be the Year of § 112 at the Supreme Court?
December 7, 2022
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.